Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
86%
Breast Cancer
73%
Copolymer
36%
Microflora
30%
Uterine Cervix Cancer
29%
Nanoparticle
27%
Neoplasm
26%
Doxorubicin
25%
Disease
25%
Micelle
23%
Colon Carcinoma
23%
Cyclooxygenase 2
15%
Inflammation
15%
Colon Cancer
14%
Adiponectin
13%
Tumor Microenvironment
13%
Prostaglandin E Receptor 4
13%
Combination Therapy
13%
Anticarcinogen
13%
Hyperleptinemia
11%
Somatostatin Receptor
11%
Gold Nanorod
11%
Beclin 1
11%
Thymoquinone
11%
Reactive Oxygen Metabolite
11%
Lung Cancer
11%
Drug Resistance
11%
Protein Kinase B Inhibitor
11%
Magnetic Nanoparticle
11%
4 (8 Cyclopentyl 7 Ethyl 5,6,7,8 Tetrahydro 5 Methyl 6 Oxo 2 Pteridinylamino) 3 Methoxy N (1 Methyl 4 Piperidinyl)benzamide
11%
Triple Negative Breast Cancer
11%
Immunomodulation
11%
Growth Factor Receptor
11%
Diacerein
11%
Celecoxib
11%
Styrene Maleic Anhydride Copolymer
11%
Liposome
11%
Transforming Growth Factor Beta
11%
Drug Delivery Vehicle
11%
Chemoradiation Therapy
11%
Multiple Drug Resistance
11%
Human Papillomavirus
11%
Tamoxifen
11%
Vasculotropin
10%
Ionizing Radiation
10%
Leptin
10%
Chemotherapy
9%
Iron Oxide Nanoparticle
8%
Acrylic Acid Butyl Ester
8%
Antiapoptotic
8%
Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
41%
Angiogenesis
30%
Disease
23%
Metastatic Carcinoma
23%
Cervical Cancer
23%
Drug Resistance
23%
Gut Microbiota
23%
Race Difference
23%
Gut
22%
Neoplasm
21%
Catenin
21%
Tumor Microenvironment
19%
Carcinogenesis
19%
Programmed Cell Death
19%
Microbiome
16%
Vasculotropin
16%
Cyclooxygenase 2
15%
Breast Tumor
14%
Triple Negative Breast Cancer
13%
Notch
13%
Bacteroides fragilis
13%
Prostaglandin E Receptor 4
13%
In Vitro
13%
Cancer Growth
13%
Immunomodulation
13%
Liver Metastasis
11%
Lung Cancer
11%
Growth Factor Receptor
11%
Wart Virus
11%
Growth, Development and Aging
11%
Prostaglandin E2
11%
Adiponectin
11%
Lung Metastasis
11%
Safety Assessment
11%
Iturin A
11%
Vascular Bundle
11%
Sarcoma
11%
Colon
11%
Reactive Oxygen Species
11%
Cancer Resistance
11%
Dysbiosis
10%
Tumor Progression
9%
Mitogen-Activated Protein Kinase
7%
Epidermal Growth Factor Receptor
7%
Tumor Cell
7%
Infection
6%
Cytokine
6%
Tumor Immune Microenvironment
6%
Immunocompetent Cell
6%
Keyphrases
Breast Cancer
58%
Microbes
39%
Breast Cancer Cells
27%
Breast Cancer Progression
25%
Mechanistic Insight
24%
Tumor Microbiome
23%
BI-69A11
23%
Metastatic Progression
23%
Breast Tumor
20%
Obesity
20%
Microbiota
18%
Cyclooxygenase-2
18%
Metastatic Breast Cancer
17%
Risk Factors
15%
Prostaglandin E2
15%
Tumor
15%
Cancer Cells
14%
Gut Microbiome
14%
Honokiol
14%
Autophagy
14%
Cancer Microbiome
13%
Notch1
13%
Label-free
13%
Microbiome Research
13%
Gut Colonization
13%
Breast Tumorigenesis
13%
Tumor Growth
13%
Leptin
11%
Microbial Risk Assessment
11%
Breast Cancer Treatment
11%
Microbial Dysbiosis
11%
Tumor Metastasis
11%
Reactive Oxygen Species
11%
STK11
11%
Pro-apoptotic
11%
Lung Cancer
11%
Oral Cavity
11%
Enterotoxigenic Bacteroides Fragilis
11%
Human Triple Negative Breast Cancer
11%
Antibiotic Use
11%
Racial Disparities
11%
Microbial Alteration
11%
PLK Inhibitor
11%
Distant Metastasis
11%
Reduction-responsive
11%
Divergence
11%
MED1
11%
Breast Cancer Management
11%
Obesity Paradox
11%
Colon Adenocarcinoma
11%
